Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorM.D. Anderson Cancer Center

About this trial

This trial studies how well dyadic yoga intervention works in improving physical performance and quality of life in patients with stage I-IV non-small cell lung or esophageal cancer undergoing radiotherapy and their caregivers. Dyadic yoga intervention may help to improve physical function, fatigue, sleep difficulties, depressive symptoms, and overall quality of life for patients with non-small cell lung cancer and/or their caregivers.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

PATIENT ONLY: Diagnosed with stage I-IV non-small cell lung cancer (NSCLC) or esophageal cancer and going to receive at least 3 weeks of thoracic radiotherapy (RT)

PATIENT ONLY: Eastern Cooperative Oncology Group (ECOG) performance status of ≤ 2

PATIENT ONLY: Able to read, write and speak English

PATIENT ONLY: Able to provide informed consent

Disqualifiers

PATIENT ONLY: Who have regularly (self-defined) participated in a mind-body practice in the year prior to diagnosis

PATIENT ONLY: Patients who metastatic disease involving the central nervous system

Trial design

Design model

Parallel

Treatments tested in this trial

  • Educational Intervention

    Other intervention

    Undergo dyadic education program

  • Quality-of-Life Assessment

    Other intervention

    Ancillary studies

  • Questionnaire Administration

    Other intervention

    Ancillary studies

  • Yoga

    Procedure/Surgery

    Undergo dyadic yoga

Treatment groups

400 Participants
are divided into 2 treatment groups
Group A: Group I (dyadic yoga)Experimental treatment 3 interventions
Group B: Group II (dyadic education)Active comparator 3 interventions

Trial outcomes

Primary outcomes

1

Patient 6-minute walk test (6MWT)

Descriptive statistics for study variables and potential covariates will be computed and distribution characteristics of the variables will be examined. The difference between dyadic yoga (DY) and dyadic edication (DE) at 3 month follow-up (3MFU) will be tested at a two-sided .05 significance level.

Time frame
At 3 months post study

Secondary outcomes

1

Patient and caregiver quality of life (QOL)

Analyses will be similar to those for the primary outcome, except that we will use a dyadic model assuming additional dependence in outcomes between patient and caregiver outcomes.

Time frame
Up to 6 months post study

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

M.D. Anderson Cancer Center

Lead sponsor

National Cancer Institute (NCI)

Collaborator